2024年11月美国养老院住民流感、呼吸道合胞病毒和COVID-19疫苗接种覆盖率
研究评估2024-25呼吸道病毒季早期美国养老院住民的COVID-19、流感及RSV疫苗接种覆盖率。截至2024年11月10日,29.7%住民接种2024-2025 COVID-19疫苗;在自愿报告流感(59.4%机构)和RSV(51.8%机构)接种的机构中,流感接种率58.4%,RSV接种率17.9%。接种覆盖率随美国卫生与公众服务区域、社会脆弱性指数水平和机构规模而异。
要点
- 截至2024年11月10日,29.7%养老院住民接种2024-2025 COVID-19疫苗。
- 自愿报告机构中,流感接种率58.4%,RSV接种率17.9%。
- 接种覆盖率随HHS区域、社会脆弱性指数和机构规模而异。
核心结论
- 解决COVID-19、流感和RSV疫苗低接种率是保护易发生呼吸道疾病重症结局住民的重点。
研究设计与样本
- 利用CDC国家医疗安全网络(NHSN)数据,评估2024-25呼吸道病毒季早期养老院住民COVID-19、流感及RSV疫苗接种覆盖率。
主要发现
- 截至2024年11月10日,29.7%养老院住民已接种2024-2025 COVID-19疫苗。
- 在自愿报告流感接种的机构(占59.4%)中,住民流感疫苗接种率为58.4%。
- 在自愿报告RSV接种的机构(占51.8%)中,住民RSV疫苗接种率为17.9%。
- 疫苗接种覆盖率随美国卫生与公众服务区域、社会脆弱性指数水平和机构规模而变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nursing home residents are at elevated risk for severe complications from respiratory viruses, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV). Nursing homes are required to report COVID-19 vaccination coverage and can voluntarily report influenza and RSV vaccination coverage among residents to CDC's National Healthcare Safety Network. The purpose of this study was to assess COVID-19, influenza, and RSV vaccination coverage among nursing home residents early in the 2024-25 respiratory virus season. As of November 10, 2024, 29.7% of nursing home residents had received a 2024-2025 COVID-19 vaccine. Among residents at facilities that elected to report vaccination against influenza (59.4% of facilities) and RSV (51.8% of facilities), 58.4% had received influenza vaccination, and 17.9% had received RSV vaccination. Vaccination coverage varied by U.S. Department of Health and Human Services region, social vulnerability index level, and facility size. Addressing low coverage with COVID-19, influenza, and RSV vaccines is a priority to protect residents who are susceptible to severe outcomes associated with respiratory illnesses.
引用
- Reses HE, Segovia G, Dubendris H, et al. Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, November 2024. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39570790. doi:10.15585/mmwr.mm7346a2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。